ARTICLE | Clinical News
SuliXen: Interim Phase I data
June 2, 2008 7:00 AM UTC
Data from four patients in an ongoing, Russian Phase I trial showed that 0.1 and 0.3 IU/kg of SuliXen produced better pharmacodynamic responses, as measured by glucose infusion rate, than 0.2 IU/kg of...